Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research, FY 05 March 7 -- April 17*

Premium
NIH Grants for Pharmacogenomics Research,
FY '05 March 7 — April 17*
City, State
Organization Name
Principal Investigator
Award
Title

CALIFORNIA
San Diego

Illumina, Inc. Oliphant, Arnold R
$76,000
Highly Parallel SNP Genotyping for a Haplotype Map
Mountain View Perlegen Sciences, Inc. Stokowski, Renee P
$1,659,385
Signature SNPs
to distinguish Yersinia pestis strains
Los Angeles University of California Los Angeles David Geffen School
of Medicine
Black, Douglas L
$415,803
Genomic Measurement of Alternative Splicing by DNA Array
Los Angeles University of California Los Angeles Liao,
James C
$1,041,832
Automated Chip-Based Metabolomic Analysis
Los Angeles University of California Los Angeles David Geffen School of Medicine Licinio, Julio
$289,962
UCLA Pharmacogenetics and Pharmacogenomics Research Group
La Jolla University of California San Diego Bourne,
Philip E
$1,080,622
Tools & Data Resources in Support of Structural Genomics
La Jolla University of California San Diego School of Medicine Kelsoe,
John R
$621,364
Genomic studies of bipolar disorder and chromosome 22
San Francisco University of California San Francisco School of Medicine Hamilton, Steven P
$1,839,941
Pharmacogenomics of Antidepressant Response
San Francisco University of California San Francisco School of Medicine Kashanisabet, Mohammed
$297,317
Validation of genomic targets
in melanoma
FLORIDA
Tampa
H. Lee Moffitt Cancer Center and Research Institute Bepler, Gerold
$293,776
Pharmacogenomics of Neoadjuvant Gemcitabine-Pemetrexed
ILLINOIS
Chicago
Loyola University Chicago Stritch School of Medicine Zhu, Xiaofeng
$294,071
LD Mapping Using Haplotype Block: Methods & Application
MASSACHUSETTS
Boston
CBR Institute for Biomedical Research Fraser, Patricia A
$283,500
Innate immune gene SNPS in African-Americans with RA
Boston Dana-Farber Cancer Institute Johnson, Bruce E
$296,779
EGFR Mutations in non-Small Cell Lung Cancer
Boston Tufts University School of Medicine Jay, Daniel G
$139,884
Proteome Signatures and Target Validation in Lymphomas
MINNESOTA
Minneapolis
University of Minnesota Twin Cities Pan, Wei
$174,500
Statistical Methods for Genomic and Proteomic Data
NEW HAMPSHIRE
Hanover
Dartmouth College Medical School Hwa, John
$319,550
Pharmacogenetics of the human prostacyclin receptor.
NEW YORK
Cold Spring Harbor
Cold Spring Harbor Laboratory Wigler,
Michael H
$518,769
Genomics of Human Cancer
Buffalo Roswell Park Cancer Institute Corporation Moysich,
Kirsten B
$84,355
Use of Stored Bone Marrow Samples for Pharmacogenetic
New York Sloan-Kettering Institute for Cancer Research Rizvi,
Naiyer A
$143,964
Correlation of EGFR Mutations and Response to Gefitinib
Albany Wadsworth Center Spivack, Simon Daniel
$153,011
Individual Promoter SNP and CpG Methylation Signatures

NORTH CAROLINA

Durham

Duke University School of Medicine Lawson, Jeffrey H
$154,000
Genomics of Peripheral Arterial Disease
Raleigh North Carolina State University Raleigh Anholt, Robert Rh
$434,740
Comparative Genomics of Glaucoma
OHIO
Cincinnatti
Children's Hospital Medical Center, Cincinnati Katz,
Jonathan D
$271,488
Using Genomics to Understand Autoimmune Diabetes
TENNESSEE
Memphis
St. Jude's Children's Research Hospital Schuetz, Erin G
$294,060
PXR: Regulation and Pharmacogenomics
TEXAS
Houston
Baylor College of Medicine Nelson, David
$596,374
Sequence and Haplotypes for Analysis of Cancer Genes
Houston University of Texas MD Anderson Cancer Center Cinciripini, Paul M
$540,814
Pharmacogenetics, Emotional Reactivity & Smoking
VIRGINIA
Williamsburgh
Incogen, Inc. Sasinowski, Maciek
$1,202,334
Proteomics software package for the detection of cancer
WASHINGTON Seattle University of Washington School of Medicine Schellenberg, Gerard D
$267,750
Genomic Analysis of Alzheimer's Disease Genes
Seattle University of Washington Thummel, Kenneth E
$440,029
Pharmacogenomics of ADRs: Calcineurin Inhibitor Toxicity
*SOURCE: US National Institutes of Health

Filed under

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.